New research suggests that leaders are concerned about how AI adoption could lead to skill atrophy in the workplace.

For decades, treatments for macular degeneration have focused on slowing, not restoring vision loss. A new retinal implant is flipping that script, turning patients with geographic atrophy into ...

Apellis Pharmaceuticals ((APLS)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...

A new trial shows that a wireless subretinal implant, the PRIMA system, restored central vision in patients with geographic ...